Hey everyone. Good morning. Lee Lowell here from smartoptionseller.com. Today is Saturday, May 14th, 2022. Welcome to another edition of our Saturday Synopsis. What do we do here? We look at charts. I show you what I'm seeing in the market and show you what I'm using to help me get into and out of trades for our newsletters. Chart reading, technical analysis is what I've been doing for the last 30 years. So I try to make these free videos to try to show you what I'm seeing in the market and try to help you up your game a little bit with your technical analysis if that's what you like to do. So sit back, give me a few minutes here and let me show you what's been happening in the markets this week. Here we go. We always open up to the SPY, the exchange-traded fund for the S&P 500. I like to use the S&P 500 as the broadest measure of the overall market, gives us a good handle on what's been happening. Now, yes, individual stocks will trade differently at times than the general market itself, but most of the time individual stocks will follow the general market because most of the time there's not a lot of breaking news on individual companies outside of their own quarterly reports every three months or so. That's where they're called. Earnings reports every three months. So outside of that, yeah, they may have news here and there about a new product, whatever, but most of the time there's not breaking news about an individual stock or company, so they'll tend to follow the general market. That's why we like to look at the indexes, follow the indexes for the most part to give us what the general mood is of the market. So where do we leave off? So last Friday, last Saturday when I made the video, we always do about a week's worth of looking at charts. So last Friday we were right around here or so and I had if we go back to that day, let me make sure that this is Friday, this bar right here was last Friday. Okay, so typically and on the charts here, these are daily bar charts. I look at the daily charts and each vertical line is one day's worth of trading and the top of the bar is the high of the day and the low of the bar, the bottom of the bar is the low of the day. Okay, so here we were last Friday at the end of trading last Friday and they said, you know, the market has been looking weak. Every rally seems to get sold, the moving averages, 20 day moving averages is moving lower, the 50 days turning lower and the 200 days flatlining here. So I said it probably looked like more selling, unfortunately, and that we really tried to, we need to have that one day capitulation washout to find the bottom. That is when everybody sells on the same day, the market gaps open, the market goes lower, everyone gives up, throw their hands up, we have this huge, huge, long one-day bar, volume spikes for the day, everyone panics and then that's exactly where the mark, the bottom shows up. Okay, so what happened this week as we move forward, we can see we had some more selling did come in, broke new lows, lower than here, lower than here, so we may do lows. Now, we had a nice bounce back Thursday it started, Thursday we had a pretty decent day down and then we started a rally back and then Friday, which was yesterday, Friday the 13th, here's the bar right here. We had a nice rally back. Now, is this the end of the bear market? Is this where the bull starts to come back for good? Hard to say.  Now, I will admit we've had a pretty good, pretty good selling come in since the beginning of April or the end of March, just this long month and a half worth of selling right here. That's, that's gotten everybody down, everybody's feeling blue and not happy. They don't want to open up their portfolio statements because we know what we're going to see, just not doing well. So this has been a pretty long, exhaustive, sometimes ferocious and aggressive selling move over the last six weeks or so. It's hard to take. So we got to reach a bottom at some point. There's going to be value, stocks have come off so far that they reach a value point where at some point, the smart money, the big money, which is institutions, hedge funds, mutual funds, endowment funds, banks, they, they're basically the ones that really control the market. And when they see value, they're going to step up and start to buy. But have we seen the ultimate bottom yet? Or this, or is this just a, you know, a bear market bounce where we'll get these relief bounces, but then it gets sold off again. So I'm not convinced that we're out of the woods yet. This was a nice relief rally, it's called. We may even get a little bit more of a bounce, you know, Monday, Tuesday, next week, we may come up to hit the down trending 20-day moving average here. This blue line is the 20-day moving average.  So not sure that's the case, but, but, but the way the market's been going, the rallies have been sold off.  We may have some more room to run up, maybe catch up to the 20 days I just said, and sell off again. Not sure yet, have to watch and wait. Let's see if there's what the volume look like. Let me add the volume in here to see if there was any kind of spike in volume. See what you want to see on like a big move down is a real big spike in volume more than your typical average range. Like here was a pretty good, these two bars right here were spikes in volume. And let's see, typically on a spike in volume, you'll get a down move in the market. So this spike in volume coincided with this day, and this spike in volume coincided with this down move. So we haven't really seen, you can actually see the volume has been tapering off this past week or so, almost two weeks worth of trading. The volume has been coming off. So there's a couple ways to look at it. You can see it as the selling may be drying up on the downside. There's less volume, so the volume of selling may be drying up, or we just haven't seen that one day capitulation yet. Let me see if I could, I think I can show you what that looks like. So here was, this is a chart of Costco and I like to use it as an example. Back on, let me see what the date was here. Here on, here's the price. This was on, let me look at my date here, March 5th, 2021. Costco was making a low here. The RSI got very oversold and we had the spike in volume right here. So this was a telltale signal that we're hitting a bottom in this stock, which is Costco. Got a spike down in the price. RSI went totally oversold and a spike in volume, and look what Costco's done since. It's just rallied up. So we go back to the SPY. So we haven't seen the RSI hit oversold levels. This one here where we had the volume spike, the RSI got almost down to my oversold levels and then the market rallied. So we can see here on this spike down and then the market rallied off of the low RSI and the volume spike, but then it got sold off again. So we haven't seen that, we haven't seen that capitulation yet that really signifies bottom. So it doesn't mean we haven't found a bottom, not saying that we had to have a capitulation to find a bottom. This could be the bottom. I mean, we've really sold off pretty good compared to where we are now. This is where we were back in March of 2021. So we've lost about 14 months of gains in just a very short period of time. You do your look back here is where we were yesterday. You scale back or you scroll back. And this was on March 24th, 2021. So about 14 months worth of gains just evaporated in a very short period of time. So there is value out there. There is value out there, the smart money needs to come in. The other thing we like to look at to see if we're getting into lows is that we like to look at the fear and greed index, which is a indicator that really tells you the mood of the retail market, participants, the small traders like ourselves. And when everyone's panicking and selling, the fear and greed index gets very, very cheap. Let me pull that up here. I show this in my newsletter the other day or yesterday. Let me bring this up on the screen. So here's the fear and greed index. This is a part of the email that I sent out to our newsletter readers. This is the CNN money, fear and greed index. And it has this scale. Everyone extreme fear. Okay. It's at a six level. It goes zero to 100. Okay. When you're extreme fear, that means everyone's just getting out. And that's the exact time that we look for a bottom. It's basically a contrarian indicator, which goes against what everyone else is feeling. When everyone's bearish, how much further can the market go down? And that's when we get the bounce and start to spike up. So the fear and greed index at six telling us the market is super oversold, super oversold. And look what happened. We got this nice bounce part of Thursday and yesterday, Friday. And like I said, it doesn't necessarily mean now the bull is going to take over and we're going to get to all time new highs. It just means we needed some kind of relief rally. The market was just way oversold. And we can look at the VIX as well. The VIX is the fear indicator tells us the mood in the market as well. The VIX has been going up, just it goes opposite of the general market. So the VIX been going up. But the last two days, you can see it started trending down as the market started to go up. So if the VIX itself could start to keep going down, the market keeps going up, we know we've hit some kind of at least temporary bottom. So back to the spy. We want to see maybe a continuation of this market next week, maybe all the way up to the down trending 20-day moving average. That would take us to maybe about 415 on the SPY. Will it get that far? It's possible. We have the momentum from Thursday and Friday. It could carry over to Monday and Tuesday. We'll see how far it can take us. And then if it does get up to the 20-day moving average around 415 or so, be wary at that point. You may get the sell-off again. Or if it can power higher, then maybe we really found the bottom here. What we can do is we can draw some trend lines here. I mean, this is a pretty steep sell-off right here. I mean, you can see that's pretty steep. The steeper the sell-off, the harder it's going to bounce. So maybe we bounce up. The trend line is almost matching to where the 20-day moving average is. So maybe we bounce up to here, to connect with the down trending upper line here. So maybe around 415 or so. If it could break above that and start to move up, then I'm feeling a little bit better. But for now, I'm going to be a little wary. If it rallies up to the line here, I may look to, if I want to get short, maybe buy some put options or sell some call spreads or something. I may try to do that. But I want to see what happens when it connects up here if it gets knocked back down. Or maybe it'll go through. Just don't know yet. Let's look at the triple queues because that follows the NASDAQ to technology stocks. That's been getting hit pretty hard too. Let me remove these old lines here. And just like the SPY, you can draw these pretty deep. This is a pretty deep, pretty strong down move. The lines don't have to be exact. Just kind of gives you a visual of what's been happening. This is pretty steep. So you can see here, Thursday and Friday, had the bounce back. And it could probably rally up to maybe, I don't know, 315 or so. And then see what it does when it comes up to this area. Will it get knocked back down and stay within the channel? Can't say yet. So those are the indexes. Eventually the market will come back and start to go up again. We have these news items out there that is taking precedence. It's affecting the mood of the market. We've got the war in Ukraine. We've got inflation is still running very high. Interest rates are rising. The US Federal Reserve is rising interest rates to help cure this inflation. COVID is still hanging around. China is in lockdown because of COVID. So that's really affecting the supply chains of many companies that get their materials and supplies out of China. Workers can't work. So that's just causing more problems. Q1 earnings are almost over. At least all the biggies have announced. Some are good. Some are not so good. But a lot of the themes are we're having trouble with our supply chains getting the material to make our products. And that will end eventually. China will get over COVID. The supply chains will open up again. Interest rates are going to go up. So inflation will start to come down. People won't be spending as much money on food and gas and all that. This will all work itself out. We've got all these news items, big news items happening all at the same time. So that's keeping the market on edge. And once we get through those story lines, then the market will start to go up because there's value down here. Stocks have really come off pretty good. Let's take a look at some stocks and see just how far they've come off. Let's start with Apple. Apple, you look at these violent moves. When I open the chart up a little bit, you can see how strong the selling has been. When I close it up like this, you're like, oh, it doesn't look that bad, right? So it's all sort of in the perception. When I open it up, then it looks a lot scarier. It went from about $180 all the way down to $140. $40, but it was pretty big, pretty big move for Apple. I mean, it's kind of coming down to this waterfall, big selling vertical move down. Our side is not completely oversold, but Apple's given up a decent amount of money. $40 a share is a big move for Apple. Now, we can sort of see this right around the $140 level. We've got this support area, right? So that seems to be an area to target. If you're itching to get long on some shares of Apple, the $140 level has some good support going all the way back to last June or so. So there's going to be buyers here. There's going to be buyers stepping in around $140 to defend that level. And that's exactly where you can see. It just came right down to just below $140 on Thursday this week, but it bounced along with the rest of the market. So we'll see what happens. AMD, sort of the same thing. We had this 100 level, which was a support area I'd been buying around in the low 100s as well, fell through it. These horizontal lines, I've drawn the last couple of weeks to show the next areas of support. I said the 85 to 90 level should be the next area of support, which is right here around 85, because if you scroll back, here was the last support area. And it had bounced right around $85 or so this week, bounced up pretty good, closed at 95. We got into a trade this week on AMD. We sold in our credit spread, put option credit spread newsletter. We sold some put spreads with some cushion down below, giving ourselves some cushion, hoping to see AMD rally back up. I like AMD for the long run. It's a chip stock. Computer chips. Computers aren't going away. AMD is not going away. There's some value down here. So we want to see that rally back up. Let's look at Tesla. Tesla had a big move this week as well. Okay, topped out around $1,150 beginning of April, went just below $700 on Thursday. Rally back had the bounce with the rest of the market. Could we see 700? The 700 level, sort of a support area. If you go back to last June, you can see around $700, there was a decent amount of activity. At first it couldn't get through 700 here, popped through it, came back down, and then finally got above. So $700 seems to be a level that has lots of buyers and sellers. And it looks like right now it's the support area. Bounced here, bounced here, broke through it last summer here in August. So $700 seems to be the magic number for now as far as potential support. So we'd like to see everything start to bounce. Amazon just been crushed of late, almost hit the $2,000 mark. Let's go back to see when Amazon was near $2,000 a share. Stay with me and let me move myself a little bit here. We'll look at the monthly chart. So Amazon last time was at $2,000, was right around here. And I'll tell you the date was April of 2020, just like right after the COVID low. So Amazon's gone up and then just in a few short months has given back two years worth of gains in a very short period of time. So Amazon has gotten pretty close to oversold levels. Let's see what the volume looks like on Amazon. See if we got any kind of spike there. Okay, so here's a spike. Let's take a look at the spike. So here's the volume spike, which was right after the earnings announcement. Right, you can see the gap here, the air pocket volume spike, but Amazon kept going lower, kept going lower for another $500 a share. RSI is getting oversold right around Wednesday this week. So Amazon might be putting in the low for a period of time. You get the got the bounce. Maybe it'll tick back up to $2,600. So that's where the downtrending 20-day moving averages. So if we get a couple more days of up move, Amazon's going to jump pretty good. It could even jump all the way up to $2,600. But damage has been done. So that's Amazon.  So we go through some of the really expensive stocks that got hit pretty good. We could talk about Shopify, you know, $1,700 all the way down, got down under $400 this week, even down to, let's see what the low was here this week. This bar was the low $308. So that's a big move on Shopify. A lot of these tech stocks have just gotten hit this week. You know, I went through them all recently. Just if you're in these tech stocks, these Momo stocks, they've all been, they've all gotten hit pretty hard. But let's look at some stocks that have been doing well. We're not, I don't want to be all doom and gloom here. Coca-Cola, still a strong stock, a stalwart dividend, aristocrat moving up, looks a lot different than the other stocks we're looking at where they're all going down. Coca-Cola looking good, had a nice day on Friday. You know, if you're looking for the stalwarts to hold and have forever and ever, you know, Coca-Cola is one of those types of stocks. Good dividend payer, Pepsi, Pepsi and Coke, right? Pepsi looking pretty good too. It's got the nice up-trending chart, not the down-trending chart. You know, these strong stocks you can buy in the pullbacks on the, you know, the 50-day or 20-day moving average levels. Yes, it got hit with the rest of the market back in February and March, but it still maintains its upward momentum. Some of the energy stocks, ExxonMobil, energy stocks have been going up. I've talked about ConEdison before. Ed, here's the ConEdison. This is the utility company, utility company's going up. So there are some select stocks that are going up. Look at that dividend aristocrats list I've given before. You can look at, build your watch list there. Let's take a look at some other stocks. We've got the healthcare stocks, Johnson & Johnson, healthcare stocks, looking pretty decent, Merck. We're all going to need healthcare. We're all going to have to see doctors and get medicine throughout our lives. So healthcare, pharma companies are doing okay. This is Merck. Pfizer, talked about Pfizer many times. You know, Pfizer could be making a base here. Glaxo, GlaxoSmithKline. You know, all these healthcare stocks are going up. We look at the XLV is the healthcare ETF. Now we have a position in that. You'd be surprised that, you know, you think the healthcare stocks are going up. The XLV should be going up as well, but it's sort of been flatlining here. We're in a, we put sell credit position selling, put option credit spreads, hoping for the bounce here. But we always play with cushion. So XLV, if you want to get a smattering of healthcare stocks, let's see what else we got. Let's check out the list, get our list here. Let's see what we have. A Walmart. We always like to look at Walmart. Another stalwart. Had been in this range, went up nicely. It's got a pullback here. Getting close to the 50 day moving. This is actually the 200 day moving average right here. This is the 50 day, 50 day here, 200 day here, 20 day here. So Walmart coming on a pullback, pullback about $12 per share from its highs. So, you know, if you want a stalwart, Walmart, we look at Disney as well. We're looking at these big stalwart companies, these well known brands. Disney just been getting hammered. I've been buying around the 130 level. I'm underwater on the position, but I'm, I'm having and holding for a long time. Disney's a great company. And the, this is just the, for me, I believe is just a temporary sell off. And eventually the market's going to, the stock and the markets will go back up. So, you know, and I've also been nibbling a little bit more on the way down because I'm going to hold for a while. Disney's a great company. I just don't, it's hard to see how it's coming off so much. I've been selling some way deep out of the money puts as well. That's what we do here at smartopsandseller.com. Let me just quickly pull up our website. If you want to learn a little bit more about put option selling, that's our specialty bread and butter. Go to our website, smartopsandseller.com, click on the put selling basics link right here. And it's a free report, free guide, free e-book. Put your name and email address in here and we'll send you a free copy. All right. So, let's go back to the charts. Disney, you know, getting, getting close to oversold levels on the RSI. I'm, I'm, I'm a, I'm a little bit of a buyer here, still on the way down. I'm going to have and hold forever. That's just me with Disney. Great company. Let's go back to the long-term monthly chart. Here's the COVID low, right around $80 a share.  I think there's value here in this area. That's just me, not a recommendation. I'm just showing you what I'm doing. Same thing with Nike, another brand on the same level as Disney. Nike just getting hammered as well. Well, you know, some might see this as buying opportunities. Let's look at the monthly, you know, look how great Nike's been doing. And it's just been having, having this pullback, pulling back to the 50 week moving average right here. Is it a buy area possible? If you like Nike for the long run, you know, it's a great company. Sell millions and millions of sneakers and apparel every year.  You know, it's hard to buy on the way down because you think it could keep going lower. But you know, I'm personally, I nibble, nibble along the bottoms, try to catch for a turn. No, not putting it all out there, just bits and pieces to hold for a long period of time. Let's see what other stocks are on the list that we can look at here. Netflix, Netflix hanging, hanging around their lows. Here's a, look at the oversold here on the RSI, oversold here. Let's look at the volume. So if we got some spikes, look at that, that spike right there. But that was on the, the air pocket on the, the earnings announcement and but the price action kept going lower. But you've got the divergence of the RSI right here. When price action keeps going lower, but the RSI starting to trend upwards, that means the selling is slowing down and we may have the turn, the turn upwards. Let's remove the volume so we can see this a little better. So we've got the, the little bit of a turn upwards here the last two days, just like the rest of the market, RSI going up as well. Has Netflix found the bottom? Hard to say. It could rally up a little and then get hit back down again. Don't know. Facebook, sort of the same thing. Earnings announcements, just knocked it back down. Earnings announcements here brought it up, but it's been sold off again. I don't really like to play much with Facebook. Twitter, Elon Musk said yesterday that the deal is on hold while they work out some more kinks. Still doesn't mean that the deal is going to go through. So obviously stocks come down, Twitter's been coming down. The buy price is $54.20. We're at $40.72 now. He may be making a play to try to, to renegotiate a different price, a lower price, lower than $54. We'll see. Does he have a legitimate gripe about too many spam accounts on Twitter that they didn't tell him about? That's what he's saying. Price has been coming down. So we'll see what Twitter's doing. We don't have any positions in Twitter. Let's see what else we got. Verizon, still hanging in the lows. Kellogg, Kellogg doing pretty well. Serial, making a lot of serial. People still at home eating lots of serial. Kellogg's PayPal. Let's take a look at PayPal. We sold put options on PayPal with about a 50% downside cushion. Hoping to see PayPal get a bottom here. Still coming down a little. RSI slightly moving upwards may have found a bottom here. I just can't believe a stock like this is still just coming off so much. The payment sector, PayPal, Square is the other big player, still getting hit as well. I mean, eventually these stocks are going to find a bottom. We just have to wait it out. We've got lots of these news headlines still out there. We're all in the same boat.  We all have to endure these sell-offs at times, but we know as we look back at the SPY, let's look at the long-term chart. We know the market goes up over time, but we have to endure some pullbacks along the way. If you've got the time and the patience, then you will be rewarded in the long run. That's just how investing in the stock market works.  You know, you got to try to catch the swings up and down. In our newsletter, our time frame is about a couple months.  So we have to be pretty good with our timing to try to catch these bottoms. So we've been very light. We've been hanging off on the sidelines, not putting our money at risk, because we know the market's just been coming down. It's a little bit too treacherous for us to really put out a lot of new positions, because if the market keeps coming off, then we may get stopped out of more trades and lose money. We don't want to do that. So we're kind of hanging back a little bit, more money in cash. Cash is a position to have, even though you're not really earning a lot of money on your cash, at least you're not losing it. So we're taking it light. That's just how it is. The market telling us to stay out, we stay out. Okay. Let me see if there's any other stocks that are worth looking at. McDonald's is kind of hanging around. A Warren Buffett, you know, even Warren Buffett's stock's been coming off, but hanging on this now the 200-day moving average support area. I've showed you on our website, we have the Warren Buffett report that I wrote about a trading strategy. You can go on our website and take a look. Let me see if I can show you where it is. Here on our website, if you go to the more tab and you click on shop right here, go to the more tab, click on shop and you'll come to the Warren Buffett trading strategy report that I wrote that may interest you. So Warren Buffett, you want to piggyback him? Take a look at that report. What else we have? Bitcoin's been coming down this week, gotten under $30,000. So Mara and Riot, the Bitcoin stocks have also been moving lower. Bitcoin seems to be tracking with the stock market as well. Those are all going down eBay. That's about it. That's about it. I think of notable stocks. Just scrolling through the list here. Costco has gotten hit this week as well, fell below the 200-day moving average. Like I said, there's a point where value comes into play. People are going to step up and start buying these stocks. I think that's it for the notables Oracle position. We still have Oracle. We still put options on Oracle, waiting for that thing to come back for the bounce. $70 seems to be support right now. So we're waiting. We're waiting. All right. I think that'll do it for me here. 32 minutes in. I hope this gives you a decent idea of what's been happening. Let's quickly take a last look at the SPY relief bounce on Thursday and Friday. We may have some follow-through Monday, Tuesday, this week. Look for the downtrending channel and the downtrending 20-day moving average to catch the next potential resistance area. Will it knock it back down or will it muster enough muscle to break through and start the next leg of the upside in earnest yet to be seen? But watch this area on the SPY, maybe around $415 level. See what happens. All right. That's all for that. Remember, go to our website. Get that put selling basics guide. And I hope this video has been helpful. Give me a thumbs up in the YouTube video. Don't forget to subscribe. Hit that red subscribe button. Leave me a comment. Send me an email. I'll answer your emails. Don't forget to follow me on Twitter as well in the video description. You can see my Twitter link. All right. That's all for me today. I hope everyone has a great weekend and a great trading week ahead. I don't think I'll be around the next two weekends. Got some family obligations, graduations. Then it's Memorial Day weekend here in the U.S. So I'll probably see you back here in a couple weekends. All right. That's all for me today. Take care, everyone. This is Lee Lowell signing off.


Hey, guys, welcome back to my YouTube channel. This is Daniel Rosal here. I wanted to record a video about a really, really useful YouTube extension I just came across. It's called MultiSelect for YouTube, very deservedly one of the featured extensions on the Chrome Web Store. I've added it. Let me just show you how it works. So what I've done here is I'm currently in the process of building out a couple of YouTube playlists for language learners. I'm learning Hebrew. And I discovered a few days ago how to automatically translate captions from Hebrew and into English or from any language for that matter. So I'm in the process of building this big playlist. And I'm using mostly at the moment videos from Cannes, which is one of Israel's public broadcasters. So basically, I'm adding the ones that have subtitles into this playlist from their content repertoire. And you can see that some of them are not others. Now let me just take off the extension for a second and show you guys. I'm going to refresh now on this page. This is how YouTube looks regularly like, right? And what I was doing was going into add this video, add this video, skip this video, one by one by one, and incredibly, incredibly inefficient. So I figured there might be a plugin searched for MultiSelect for YouTube and discovered this. Now let me go ahead and turn this back on. Turn this back on for YouTube refresh. And as before we can see, it's now added these boxes under each video. So I can much, much more efficiently select one, two, three, and four. Now it's also added these second level context menus instead of having just the first level up here. It's created kind of, I'm going to call these phantom ones under the YouTube video. And just like the real ones, you're able to save to watch later, add to queue or save to playlists. What I'm going to do now is click save to playlist. And to show you guys how it works, I'm going to just create a test playlist two, set it to private and we should. If I go into test playlist two, we can see the four videos were added at once, which is amazing. So it's also visible on this page as you can see. So it's really not just for creating playlists, it's for managing YouTube videos more efficiently in general. In terms of the options you have here, it does give you a little context menu where you can hide it on the homepage, trends, subscriptions, library history, et cetera. So depending on what you're going to use it for, for instance, I'm using it in search results, right? So if you weren't using it, you could turn it off there so it doesn't kind of clutter up your YouTube or you could just turn it on and off when you're actually using it. So this is really, really good. I am going to buy this person a cup of coffee now because as a Hebrew learner learning through YouTube videos, this is going to make creating playlists for watching like so much more efficient. So really, really useful. Again, it's called multi-select for YouTube. It's available on the Chrome Web Store.  Thank you guys for watching. More videos coming soon.


This is an international food safety icon about proper food storage. This symbol appears when a specific food safety message about proper food storage is being described. Refrigerate foods quickly to slow the growth of harmful bacteria. Do not overfill the refrigerator. Cold air must circulate to help keep food safe. Keeping a constant refrigerator temperature of 40 degrees Fahrenheit or 5 degrees Celsius or below is one of the most effective ways to reduce the risk of foodborne illness. Refrigerate perishable foods or freeze as soon as they arrive from your supplier. Never let raw meat including poultry, eggs, seafood and cut fruits or vegetables or cooked food sit at room temperature for more than two hours. Divide large amounts of leftovers into shallow containers for quicker cooling in the refrigerator. Keep all potentially hazardous foods at a safe temperature. Keep cold foods below 41 degrees Fahrenheit or 5 degrees Celsius and hot foods above 135 degrees Fahrenheit or 57 degrees Celsius. Always marinate food in the refrigerator. Never defrost foods such as meat, poultry or fish at room temperature. You have three safe ways to defrost food. One, in the refrigerator. Two, under cold running water. Food thawed in cold water must be used immediately. Three, in the microwave. Food thawed in the microwave must be fully cooked immediately. Keeping cold foods cold and hot foods hot will help you keep your customers safe.


Stephanie, last month you were in Afghanistan. What was the purpose of your trip and what were the places in Afghanistan you visited? A team of five CSIS personnel went over to Afghanistan, predominantly Kabul, but also down in Kandahar and Helmand, which two areas in the south, areas which have seen them fiercest fighting in the war to date. Our primary purpose, though, was not to look at the security situation, it was to look at the economy of Afghanistan and ways in which the U.S. government can help it along. What were some of the findings of your experience there and how much has Afghanistan grown in the last decade and is the growth accelerating? Our primary purpose was to talk to not only U.S. government officials in Afghanistan, but to local vendors, the Afghans themselves, to talk to them about how their businesses were doing. Back in 2002, at the very start of this operation, the economy was very much agriculturally based and as anyone would tell you in development, the basis for furthering the economies of countries is manufacturing, so we were looking at both agriculture and manufacturing base to see really where we can help the most. Has there been a shift away from the poppy trade, the illicit drug trade, to more legitimate agricultural endeavors? I really wish there was a good news story here, but if you look at the UN's numbers, the poppy trade is a robust cash crop for Afghan farmers. It's really difficult to shift them away from such an easy crop. It is actually not that intensive a crop to grow and it's very easy to sell given the world demand for it, to shift them towards things like almond trees, fruit trees, things that can grow in the very rough climate of Afghanistan and that are sellable on the international marketplace. But it hasn't happened. It hasn't happened. In fact, agriculture has seen truncated growth in recent years. They are trying to shift towards manufacturing. That has been in large part to the U.S. government and coalition donations to help things like textiles, things like shoes, things that can not only be bought in Afghanistan but can be a comparative advantage within the region and be sold across the border. So are there any bright spots? Are there any good stories that you found over there? I will say Afghan people are very resilient people. They've had to be over the last few decades. And then when you talk to them, they want to give you everything. They want to not only be the transportation for your goods from point A to point B, but they want to provide those goods to you. So you see a lot of travel agencies, for example. Travel agent owners telling you that they want to grow pomegranates for exports, that they want to create the shoes that you're wearing or the clothes that you're wearing. And I think that is a really good news story. We have a lot of business people in Afghanistan wanting to take that next step. Interesting. What can the U.S. government do to better support Afghanistan's development? From the very beginning in Afghanistan, we've been so focused on building facilities for our troops, helping our diplomats along rule of law, governance lines. Economic development is really the next step. And we need to study what sectors are the most viable for sustainable growth in Afghanistan when the U.S. government departs, or at least when the U.S. military departs by the end of 2014, there may be a slight recession because we've infused so much Department of Defense money. The goal right now for the U.S. government, the way in which we could be most helpful, is to identify those sectors and help them along so that it is sustainable growth in the future. Let's just talk about the drawdown. What kind of impact do you think that's going to have on the economy? The U.S. military withdrawal will have a tremendous impact on the Afghan economy. Not only will the troops be leaving and therefore not require construction, not require some of the services that Afghan people provide, but they're going to take their money with them. A lot of our foreign assistance to Afghanistan has been funneled through the Department of Defense, whether it's through something called the Commander's Emergency Response Program, which is fast infusions of money to local economies, ranging from that all the way to hiring people to deliver gravel to bases. And so when the U.S. military withdraws, if they take all of that money with them, you are absolutely going to see a recession. And you're going to lose jobs and there's going to be... So is there any plan right now for the U.S. to try to help mitigate that? There is an office within the Pentagon, oddly enough, called the Task Force for Business and Stability Operations. Its mandate is to help private sector investment to get U.S. companies and international companies involved in the Afghan economy so that when the U.S. military withdraws and takes its money with it, that there is some sort of backstop for sustainable growth. Again, U.S. government is trying to identify sectors that are comparatively good within the region for Afghanistan to be able to export across its borders, but it's going to need a lot more private investment and perhaps also donations from other countries. But it's almost a double-edged sword because with military, with U.S. military withdrawing, it provides a less secure climate for international business, correct? Absolutely. There is two sides of this coin, and not to be funny about the counterintensity acronym, but there are two sides to this coin. One is you need security to create an environment in which businesses can thrive, but you also need an economy that will take people off the streets and get them jobs as opposed to, for example, implanting improvised explosive devices along the roadside. And so it is a delicate balance you need to strike between security and economic security. And that's something where I think the U.S. government needs to spend quite a bit more time thinking. Stephanie Sannick, thank you very much for your time. Thanks.


Hey everybody, I wanted to come on really quick for a quick happy mail and vlog I got some happy mail from Victor from Ukraine and he sent me this really great handmade card Look at that For a guy who I know who I've talked to who has limited supplies. He sure doesn't make cute stuff So it looks like it's just made out of regular paper some repurposed materials and old map Doodle, I just love it and then he included an ATC card That says just autumn. It's fabulous. I Love it. So there's that. Thank you so much Victor I really love it and a great envelope to add to my stash because I'm still collecting envelopes for that Envelope junk journal that I saw somebody else make I think on junk journal junkies and now I've got to make one I Was cutting up your happy mail envelopes and using bits and pieces of them in my journals and I should have been saving them because I yeah, anyway Hindsight it's always 2020, right? So I got another packing package from my friend Cindy udder from New York And I knew she was sending me something In particular she told me she had an extra one of these handmade watercolor books from Hobby Lobby Because I told her I was going to go buy one and she said don't I have one I'll send it to you Thank you so much, and I haven't even opened it yet because I wanted to do that on camera with you guys I can't wait. I keep hearing such good things about these journals Oh, and I can just tell you by just feeling the cover I'm already in love with it. Let's see if I can get this open without ripping the label Or at least without ripping it too much Okay, there we go The cover is made out of handmade paper as are the pages inside Oh, and I gotta tell you guys, you know, I like my watercolor paper textured. I don't like smooth watercolor paper and This is just wonderfully textured. It feels like cotton What is it? Probably it's up 100% post-consumer waste. So it's a recycled watercolor paper journal I love that and it's a stitch bound Fabulous fabulous fabulous. Yeah, you can't wait to work in it. And then what I didn't expect was she included a bunch of extra things Which I didn't expect She got some of these really great tags Well, these are from her husband has a firearms business and these are some of the tags from his firearms business I think he's closing up shop Anyway, and she got these really great paper clips. I think they're supposed to be alligators But she sent me a bunch of these tags with look at the clips clips are cool So she sent me a whole bunch of them. I didn't expect that. Thank you so much We I know we talked about them But and then she sent me some really fun bits and pieces of textured paper and these are like corrugated cardboard They're gonna be great on the jelly plate and Then she sent me some cork paper Really cool cork paper Look at this one. I Like that one and then some burlap paper. I just want to you know rub on it I know it'll make me itchy later, but And then she had gone to The Mudder Museum Which is one of those museums of medical curiosities and she picked up a brochure With this interesting drawing on it that she sent me a copy of To use is that cool or what and then she put a note on another tag Oh, I didn't even see the backside on another one of the firearms tags And she's decorated this one with some of her painy doodled paper. Look at that Love it. Thank you so much I love all the bits and pieces that you sent Cindy and vicar. I love it. Love it. Love it I can't wait to work in that journal What else is going on today my camera is doing weird things today, so hopefully it's recording okay, and it'll download Okay, I don't know it was doing something weird. I might need a new SD card How long are they supposed to last? I oh I Created a new Page on my website Gina be errands calm the link for it should be in the description below today is what's today the 18th Of September and I was looking out like it's like calendars up there That is called inspiration photos or inspiration pictures something like that so pictures I've taken And in some cases I took them and I've altered them in an app, but they're all photos I personally have taken Are on that page and they're free for you to download and uses inspiration in your artwork Some of them you will see in upcoming videos on my YouTube channel I'll be using the photos some in watercolor Wednesday some in Monday with deco art So that being said as of the 18th the page is up. I don't know if anybody's noticed yet, but it's up Yeah, yeah, yeah, I think that's it right now. I think maybe I Don't know maybe all right, so don't forget to like share and subscribe and You know tell your friends about my channel If you have any questions comments or concerns Please feel free to contact me all my information in the description below and of course leave a comment on the video I do respond to them within a day or two I'm trying really hard to be better at that because it used to take me a week to respond to comments now I'm really trying hard like every evening After dinner I'm on the You know one of the devices around the house is not like there's not plenty of them replying to comments If you have any Products you'd like to send me to try and review My PO box is also in the description below. Of course if you want to send me happy mail my address is down there and I think that's it. Have a great week weekend Day whatever I don't know for sure when this is gonna air. So But have a great something and don't forget to go out and do something nice for yourself because you deserve it All right, I'll see you all later. Bye


pro-chancella, council members, members of the university, special guests, graduands, families and friends. I extend a warm welcome to this, the 4th autumn graduation ceremony for 2011 of the University of Auckland. This week the university is bestowing a total of 6,579 qualifications on 6,051 students. At this ceremony degrees will be conferred and diplomas awarded in the Faculty of Medical and Health Sciences, so a 480 in person plus a further 126 in absentia. It is my great privilege as Chancellor to preside at autumn graduation for a third year. The scale and frequency of graduation ceremonies makes them no less special for the university and me personally than for those of you being capped here today many for the first time. Graduation is a festive event rich in history, pomp and colour with a lively array of contemporary touches. Here in Auckland our rich mix of cultures and ethnicities is evident in the striking variety of dress and adornments worn by the graduands.  The university represented by the council and academic staff members seated behind me and those many staff who control proceedings with remarkable precision takes equal pleasure at this hugely significant day for each and every one of you. The University of Auckland is the only New Zealand university ranked in the top one percent of the world's universities. Your qualifications will always serve you well in New Zealand and abroad whether in equipping you for a satisfying career or in leading to more advanced study or simply as a route to personal and intellectual enrichment. In today's fast changing world more than ever you cannot afford to stop learning so please keep in mind the enormous range of postgraduate opportunities this university offers. Whatever path you follow I urge you as alumni of New Zealand's leading university always to remember your alma mater. We depend increasingly on our graduates for support, moral, political and financial. Your advocacy and influence are vital in encouraging government and the community at large to fund universities so they can generate the knowledge needed to drive a productive and competitive economy and to create a full and satisfying life for New Zealanders. At the same time philanthropy has become critically important to our university, funding major capital projects, scholarships and professorial chairs. The crucial contribution of major research universities such as ours is not well understood. Our innovative research is vital for long term sustainable economic growth and social cohesion. Never more so than in the difficult economic times New Zealand now faces in the wake of the recession and the two Christchurch earthquakes. Universities are quick graduates like you, not simply for the jobs of today but for future careers not yet imagined. Universities need greater investment by government, the commercial sector and private philanthropy not less but that's sufficient for me on the challenges facing academia. For today unquestionably belongs to you the graduands and you are its primary focus. I congratulate you and trust that you will long cherish the enjoyment and excitement of your graduation in May 2011. Now speak this morning of Mr Andrew Connolly, a prominent general on colorectal sedgion in Auckland. He is a consultant surgeon at Middlemore Hospital where he is head of department of general and vascular surgery. Mr Connolly graduated MBCHB from the University of Auckland in 1987 and was made a fellow of the Royal Australasian College of Surgeons in 1994. After 18 months of formal research under Professor Graham Hill at Auckland Hospital he spent two years in Britain in post fellowship colorectal surgical training. He has strong interests in surgical training and education and clinical governance and is actively involved in clinical research. In 2009 Mr Connolly was appointed by the Minister of Health to the Medical Council of New Zealand and he is the presiding member of the Lotteries Health Research Distribution Committee of the Department of Internal Affairs. He describes himself as a lifelong Liverpool football fan and he is also an avid amateur military historian particularly focused on the first world war. Please welcome Mr Andrew Connolly. Chancellor, Vice-Chancellor, members of council, dean, faculty, graduands, ladies and gentlemen, thank you for the opportunity of addressing you today. I'm privileged to stand here today to join with you in celebrating your academic success in the Faculty of Medical and Health Sciences. It's more years than I frankly care to remember since I sat where you are but I have absolutely no regrets about the journey I took. My time at medical school gave me friends that are still my closest, gave me a sense of who I was and what sort of doctor I aspired to be and I know my nursing colleagues felt the same. I'm sure my pharmacy colleagues also felt the same about their schools. Now of course the med school is but one part of a much greater faculty and whilst a once decent car park and park road now hosts a massive new block and the cafe serves real food which is quite a revelation for us who were there in the 1980s, the importance of what goes on at park road and in the various institutions that contribute to the faculty has not diminished over the last quarter century, in fact it's only increased. You the graduates of 2011 have achieved a wonderful thing. In your chosen fields you have met and surpassed a set of standard set not only by the university and your clinical teachers but in fact by society as a whole and you have done this in one of the world's leading health faculties in one of the world's leading universities and on your behalf I would acknowledge the leadership that sits on this stage. Having met this standard you have earned the right to call yourself a health professional. With this right comes a wonderful privilege and a host of responsibilities. That privilege manifests itself in a number of ways. First it is caring for others. There is no greater public service than to dedicate one's professional life to caring for those less fortunate. At a time in a person's life when they're often at their most vulnerable, at their weakest and at their sickest, a health professional who displays simple humanity by listening is often never forgotten. Please do not doubt the importance of even the smallest gestures. You may be wondering why you studied so long and so hard to apparently be judged by small gestures but remember it is your global knowledge that allows you to begin to understand just what it means to be sick. Therefore your small gestures have real understanding behind them and therefore they are perceived as genuine. Our responsibilities when it comes to caring are legion but I think they can be summarised quite simply. Most patients, the vast majority, not surprisingly want to get better. With that desire comes a need for those who care for them to show them respect, to be thorough and professional in their approach but perhaps most importantly the patient wants to know that the health professional dealing with them actually cares. The second privilege of being a health professional is to gain an understanding of others. As a nation we have just commemorated Anzac Day. I'd like to remind you that you are some of the last classes of graduates who will have the privilege of knowing, talking to and caring for veterans of the Second World War. These people are mainly in the last days of their lives and many now only want to share a little of what they experienced. I would ask you to take time to listen to them as they may well tell you things that even their families are unaware of. The tangata whenua of this land and many of the Pacific peoples represented by you here today come from cultures steeped in oral tradition. We should all learn from those traditions and take time to listen especially when the old and the sick wish to talk. A third and great privilege of being a health professional is that we get to spend time with people like you. There is an inherent need to educate our students and each other. Never forget this privilege because it is also our collective responsibility. Remember you have all been taught by others. Some were no doubt very good and there would have been some that were terrible but all of them at least took the time to teach. As a surgeon I have the privilege of on occasions literally someone holding someone's life in my hands at least for a period of time. Yet these days I only intermittently physically cut things. I spend much of my time in the operating theatre training my registrars. When the registrar can do the operation better than me my teaching has been a success. There is one such registrar in the audience today. Each generation must strive to be better than the last and I encourage all of you to do better year on year and I challenge each of you to make the next generation better than you are.  It's natural to think no more, never again I will never again do an exam or read late into the night. Well unfortunately for health professionals learning never stops and we will never lose the need to continue to improve our knowledge and to maintain and improve our professional things. But we should see this as a good thing for the more we know the easier our job becomes. This is yet another responsibility and I suspect it's one that Professor Martin didn't mention on the open day at the faculty all those years ago. All the various councils and colleges that make up the governance of health in New Zealand are geared ultimately towards two goals. The first is a constant improvement and protection of public health and safety. The second is the training and education of the various members of those councils and colleges. Therefore we must embrace future training both as pupils and as teachers. I've referred to all of you as having obtained the title health professional. I've not yet defined what a profession is. A profession is simply one that regulates itself, a body that teaches its own, examines its own and judges its own and never doubt the importance of these rights because they are two great privileges. And again these come with responsibilities. I would encourage each of you to get involved and it's never too soon or too late. Health in New Zealand in the 21st century faces many challenges some of which will need the leadership of the professions to which all of you have now joined. When I look back after over the last 25 years I see contemporaries who've gone on to become leaders in health not only in the clinical area but in education and research and in governance. Some were late bloomers particularly in the more non-clinical areas but their list of achievements is long and significant. Have no doubt that amongst you sit leaders and it may in fact be you. Always strive to look at smarter ways to work, strive to give back to this wonderful profession and to the public we serve. Trust in the knowledge that you have been well trained. When many of you travel overseas and work you will realise just what a superb education you have had. Be proud of this but more importantly be humble enough to want to return and give back. So to you the graduates or the Faculty of Medical and Health Sciences I offer my warmest congratulations. I wish you a successful day of celebrating for those duet ward rounds tomorrow at Middlemore not too much and I look forward to seeing you grow and succeed in your chosen fields. Thank you. Thank you Mr Connolly for a very interesting speech and some wise counsellor having had a doctor for a father I recognised some of the advice that you were giving. Can I ask you again to show your appreciation please to Mr Connolly. This is a meeting of council and convocation of the university for a ceremony of conferring degrees and awarding diplomas. At this ceremony the pro-chancellor Ian Parton and I will be conferring degrees and awarding diplomas. I now invite the pro-chancellor to award the diplomas and confer the degrees in the first half of this ceremony. Thank you Chancellor. By the authority vested in me by resolution of the University of Auckland Council I Ian Parton pro-chancellor confer the degrees and award the diplomas stated upon those who within their faculty have satisfied the requirements of this university. I call upon the Dean of the Faculty of Medical and Health Sciences Professor Martin to present graduands in that faculty. Pro-chancellor as Dean I have the honour of presenting to you the students qualified for the award of a diploma or conferment of a degree in the Faculty of Medical and Health Sciences. Diploma in Pediatrics Denusha Ellen Young to the degree of Bachelor of Health Sciences Ruth Francis Aston Shivanti Kumari Bilala Neely Irene Barker Daniel Michael Burge Shishen Kai Ashmeeta Chand Wanchen Chang Rebecca Robin Crichton Amosa Junia Edwards Kalasita Nami Fale Yuan Gong Fakaosi Junia Hosea Haimata Maithana Narpia Tiana Herman Kelly Louise Bonney Hunt Anne Jonathan Hunt Kalpuna Maheshi Jayanatha Carissa Joy, Senior Scholar in Population Health Pai Fen Lee Hitesh Prasad Lokhan Mary Adley Ayad Lokha Lin Tao Mariette McFarland Davuksha Naidu Rochelle Cardine Newport Yvonne Yuen Ng Monique Arena Palaoni Roxana Mary Paracha Sheena Patel Melita Allison Rigomoto Monika Sammi Junty Tak Teima Nehemi Tuiala Tuilagi Antonia Claire Verstappen Jung Lan Yang To the Degree of Bachelor of Medicine and Bachelor of Surgery Ahmad Nuriman bin Ahmad Nazia Mele Vangana Amanqi Sarah Jane Ashcroft Timothy Glenn Ascoland Nora Fika Binti Ayub Mohamed Najib Aziz John Barnard Angela Audrey Bailey Maren Charmaine Yulin Bennett Cynthia Frances Benny Sarah Jane Benson Cooper Sarah Catherine Bowie Oliver James Rawlinson Break Holly Eleanor Britton Anthony David Buddle Cameron Robert Burton James Andrew Campbell Alexandra Claire Cardinal Chan Kin Chung Mary Emma Imelda Chiangwai Rini Sojanaya Cheguidi Joseph Chi Yong Chen Jamie Wenji Chung Lisa Karen Dawes Manikaguadu Janaini Kashlaya Desilva Senior Scholar in Medicine and Surgery Pranali Shashank Desai Andrew Jeffrey Duffin Isar Hazwani Zulkithi Sarah Grace Edmonds Melindra Clive Ilikatugi Fernando Jenny Fu Jeremy John Fison Victoria Pamela Gates Brian Thomas Grainger Noel Theresa Greentree Florence Adna Gunawan Vit Hemstaputt Norman Melville Henley Jonathan Ernest Henry Thomas Andrew Edmund Herd Doran Jeffrey Hickey Wolf Fisher Scholar Rebecca Christine Higgins Senior Scholar in Medicine and Surgery Dominique Simone Hitti Chester Percival Holt Quick Timothy Alexander Hopgood Kok Chung Ho Kate Ida Houdig Mary Hung Shafiq Bin Hussin Amy Catherine Irons Joel Otto Jackson Kalpa Thorindu Jayanefa Vikram Abraham Joseph Bryce Wenatia Alan Kirini Hannah Kim Ji Young Kim Rebecca Jane Lam Kilestina Kolqi Lilova Lovolu Gailine Labar Sophie Elizabeth Leach Nicola Lilich David Kwai Leong Lim William Lin Kalpana Loganath Mataroria Potiki Linden Copper Gabriel Manahi Lynette McGoffrin Rachel Sarah McMahon Rebecca Margaret Methin Militsa Milinovic Salina Binti Mohamed Iaz Mohamed Talib Mojoud Mohamed Havitsi Bin Mohamed Nazia Gwenda Orlindalia Tokilioto Napi Dorisha Nyka Kavendra Naidu Duncan Andrew Nielson Jared Mark Noel Yixin Oi Alistair Torfilao Papaili Curtin Mariam Patel Sarah Faye Penalligan Terina Ta'aho Pollock Adele Joanna Pope Kate Elizabeth Rapson Areitra Rae Genevieve Catherine Rayner Najihar Razali Susan Caroline Reeder Jason Paul Robertson Matthew Byron Rao Cheryl Lea Ruorau Claire Russell Peter Spencer Russell Achana Selvakumar Sriharan Selvaratnam Robert Yue Shrao Yaewon Shin Rebecca Jasmine Shine Natalia Sojadi Victoria Kate Stiebel Matthew William John Street Michael John Stubbs Trin Quachsu Sayed Mohamed Bin Sayid Abdul Hamid Hoikyat Tan Yu Mi Tan Senior Scholar in Medicine and Surgery Amanda Marie Taylor Senior Scholar in Medicine and Surgery Leah Francis Deweyhe Sei Ying Te Amelia Feta Lea Moa Ta Fono Gefea Foa Teticitiki Andrea Jane Thomas Jenny Marie Matoe Thomas Mele Lola Tupo Ursula Vandenhever Samuel Poriana Wall Wan Noor Hafizal Binti Wan Baha Rudin Millie Yu Wang Luke Kalihuot Ward Emily Fuanala McCrena Webster Casey Ann Weddekind Delanga Kushalan Wirakodi Madeleine Margaret Wells Catherine Louise White Ditlendra Raseeth Wijanayaka Jonathan Robert Arthur Wills Waikiat Wong Wei Long Wong Peter Allen Wood William Zeng To the Degree of Bachelor of Nursing Dar Yon Bai Katrina Murray Bennett Curry Danny Briers Luke Douglas Burgess Judith Alice Burnett Emerald Briar Campbell Jenny Aichung Chen Grace Carmel Cobol Chu Amy Louise Cryer Elise Alexandra Michelle Davies Jefferson Deray Lianne Ashita D'Souza Megan Joan Elliott Alexandra Fife Senior Scholar in Nursing Carla Christine Joyce Aginagonda Sarah Nicola Goode Mia Hamala Kerri Lynn Hutchings Andrew Goodwin-Jones Huyun Tsu Zhong Sophie Alexandra Knight Alice Li Dong Yuan Li Ying Li Janet Ting Ting Liu Samuel Desmond Lofren Kristen Jane Lovell Suzette Rose McClellan Emma Kate Miller Mayanas Mozadeg Janine Myers Chan Mi Oh Liana Deborah Penney Chloe Grace Christine Pennell Natalie Claire Sargan Tuy Shanti Sion Stephanie Sekuera Senior Scholar in Nursing Paul Rohit Shah Jan Nadine Manasala Siebel Caroline Susan Sneha Jasmine Bell Snoswell Phoebe Joyce Stone Sarah Kate Swaniveldo Murungi Roma Holda Tamati Latu Kelani Taafo Mary Scott Tom Liji Mariam Thomas Elizabeth Thompson Esme Marie Thornhill Yan Ha Marina Tong Mord Beatrice Tuzel Joanne Wanrong Tsai Talatiga Tutagalei Nevo Elizabeth Lacey Usher Amanda Hope Van Royen Karen Carpo Wu Nikki Segui Yero Barishna Zahra To the degree of Bachelor of Pharmacy with first class honours Jay Anna Courtney Brewster Kwan Min Jackie Chan Kaylee Ann Naidu Lina Penn Richard Thomas Perry Holly Murray Signal Harjinder Ka Sing Sashin Sunil Thakur Kunsala Tamali Diaz Samoik Ramar Yapa To the degree of Bachelor of Pharmacy with second class honours first division Aisha Sheshita Ali Rachel Lauren Blackburn Cassandra K. Butler Lisa Chang Bliss Chia Tzu Yin Aiping Cheng Tonya Kate Clark Carmen Dai Katie Lauren Davis Mary Helen Gub Dalia Hassan Yunduk Hong Sophie Marie Jones Shu Teng Kan Yuping Gao Rita Ketuola Jess Lin Li Yu Yong Li Edwin Ng Kian Lim Winnie Yi Sing Ling Stephanie Simailau Yu Jun Lu Ishmail Fathie Thank you Pro Chancellor for conferring the degrees and awarding diplomas in the first half of the ceremony One of the great pleasures of graduation is the opportunity to hear performances by students from our acclaimed School of Music Natalie Harris on clarinet and Dean Sky Lucas on piano will now perform the third movement Allegro Con for Ocal from the Sonata for clarinet and piano by Francis Poolink Performances like that from students in our School of Music and if you would like to hear further such performances the graduation concert will be held tomorrow evening Thursday at 7.30 in the Town Hall All graduands and their families invited to attend and admission is free By the authority vested in me by resolution of the University of Auckland Council Ari Roger-France Chancellor confer the degrees and award the diplomas stated upon those who within their faculty have satisfied the requirements of this university To the degree of Bachelor of Pharmacy with Second Class Honours First Division Anisha Ka Sandu To the degree of Bachelor of Pharmacy with Second Class Honours First Division Priscilla Hawa Mock Park To the degree of Bachelor of Pharmacy with Second Class Honours First Division Anisha Ka Sandu Lisa Mays-Shabbat Jessica Ling Tan Rebecca Mae Taylor Pissett Toe Janol Shao Chuo Tsai Dylan Nai An Wu Ming Yang Karen Yu Sho Yuan Zhong Zi Heng Zhu To the degree of Bachelor of Pharmacy with Second Class Honours Second Division Zainab Thama Abdul-Muzun Meina Adaim Lenati Taqai Aho Ibrahim Al Moudalal Callum Fraser Tianci Anderson Natalie Marie Antill Gina George Sobi Azair Iskander Li Yong Chang Tony Tung An Chang Navyan Diwan Amanda Lee Ikested Cheng Xiaogou Ling Fai Derek Cam Sandit Kaur Ravnet Krishan Lal Eric S.Y. Lee Kuang Chung Lu Ben Manoson Jing Miao Tian Ling Nguyen Hannah Park Rebecca Park Belinda Jane Robinson Sally Sileck Yuwei Zhou Sarah Joy Wilkinson Chung Man Mandy Wong Lun Sheng Wong Chloe Wong Tsume Rebecca Zoe Woodrow Yifei Yang Hsu Yu Ye Dan Yu To the degree of Bachelor of Pharmacy Fadiya Arif Abdul Kalik Alabu Suisi Richard Tin Yao Chan Emiao Cheng Amy Moon Jung Kim Damian Francis Mihek Wan Ho Noh Tasha Mary Reiner Amanda Thieu Timothy Tin Man Yong Ju Hee Yu To the degree of Bachelor of Health Sciences Conjoint Daniela Catherine Deteri Bell and a Bachelor of Arts Wan Ying Valery Chan and a Bachelor of Arts Jessica Hung Yi Kok and a Bachelor of Arts Kimberly Daniella Marie Maxwell and a Bachelor of Arts Tiana Missoor and a Bachelor of Commerce Louise Elizabeth Walker and a Bachelor of Arts Leah Renee Ouija Ratney and a Bachelor of Commerce To the degree of Bachelor of Nursing Conjoint Catherine Jane Carey and a Bachelor of Science Amy Carissa Rutland and a Bachelor of Science Alina Zofia Wiptych and a Bachelor of Health Sciences Postgraduate Diploma in Clinical Education Kerri Leslie Lump Postgraduate Diploma in Community Emergency Medicine Sharuk Alansari Postgraduate Diploma in Health Sciences with distinction Claire Allison Hathorell in Advanced Nursing Melanie Jane Lanigan in Advanced Nursing Postgraduate Diploma in Health Sciences with Merit Beverly Gay Bedford in Advanced Nursing Catherine Bennett in Mental Health Nursing Hannah Elizabeth Cataway in Advanced Nursing Dana De Souza in Advanced Nursing Sharon Joyce Isselli Rositza Jstoia Nova Jelitsa Culver in Advanced Nursing Honey Cecilia Marsh in Advanced Nursing Sini Parry-Cattle Chaka Pan in Advanced Nursing Shaviki Sharma in Mental Health Nursing Postgraduate Diploma in Health Sciences Sarah Jane Allen in Advanced Nursing Karen Eve Brown in Mental Health Nursing Latisha Peggy Ruth Burkhart in Advanced Nursing Geeta Shivani Chandra in Advanced Nursing Leah Marie Dixon Lisi Fuolagi in Advanced Nursing Darrell Jane Francis in Advanced Nursing Yuwen Huang Mohammed Kabeer Hussaini Selani Ayolu in Advanced Nursing Dorothy Tsitsi-Jamaila in Advanced Nursing Roberta Rae Kayo in Mental Health Nursing Malvina Kumar in Advanced Nursing Manchi Kwok in Advanced Nursing Tsupreya Maharaj Jillian Margaret Martin in Advanced Nursing Catherine Crossen McLeimont in Advanced Nursing Kahui Dekopa Neho in Mental Health Nursing Marie Niclou Mwama Therese Nhu in Mental Health Nursing Bernadette Veronica Penney in Health Informatics Mary Charlotte Roberts in Advanced Nursing Cheryl Mary Ann Roberts in Advanced Nursing Nomala Sammi in Advanced Nursing Taufimalo Sopolo in Mental Health Nursing Deborah Roslyn Mary Sharma in Social Work Kamal Nan Singh in Advanced Nursing Postgraduate Diploma in Māori Health Roseanne Janice Young Postgraduate Diploma in Pharmacy Practice with Distinction Elizabeth Ann Olliffant Postgraduate Diploma in Public Health with Merit Jillian Kaur Balbia Singh Siobhan Fa'a Vaadhafi in Pacific Health Idid Forrester Natasha Tania Goh Jennifer Frances Johnson Vicky Louise Masson Leah Adrid Palapah Jayshree Ramesh Sukar Ruta Josephine Stevenson Te Ugar in Pacific Health Postgraduate Diploma in Public Health Andrea Margaret Bidwa Pankti Kansara Saini Taumafalau Manu Opa Na'i Janice Jiwon Park Michael Vincent Walker to the degree of Bachelor of Health Sciences Honours with First Class Honours Sam Emmanuel Jed Horner Runmali Belanavida Nalagani Priyananthi Jayasinga Amanda Rochelle Wood Cenghuswe Yi to the degree of Bachelor of Health Sciences Honours with Second Class Honours First Division Delia Catoros Lyres Mai Reston-Freeth and a Bachelor of Health Sciences Jenny Gautam University Graduate Scholar to the degree of Bachelor of Human Biology Honours with First Class Honours Kylie Ellen Edwards and a Bachelor of Medicine and a Bachelor of Surgery to the degree of Bachelor of Medical Science Honours with First Class Honours Sukdee Singh in Medical Science University Graduate Scholar to the degree of Bachelor of Nursing Honours with First Class Honours Gemma Elizabeth Obann to the degree of Bachelor of Nursing Honours with Second Class Honours First Division Murray Chris Dela Cruz-Gabasan to the degree of Master of Clinical Education Wayne Anthony DeBeer Peter Charles Fleischel to the degree of Master of Health Management with First Class Honours Matthew Jason Glasgow to the degree of Master of Health Sciences with First Class Honours Alexandra Faye Graham Boyle Rachel Ann Butler Si Yu Luong King Chi Lu Smita Ravi Tipiraju to the degree of Master of Health Sciences with Second Class Honours First Division Vera Sabine Bar Manju Basahini Kanamala and a Postgraduate Diploma in Health Sciences with Merit in Pharmaceutical Science Claire Samantha Mayes Jamie Martin Robinson and a Graduate Diploma in Health Sciences Amanda Marlene Smith Tania Michelle Waitokia Claire Louise Whitehead to the degree of Master of Health Sciences with Second Class Honours Second Division Jainesh Shia Malshama to the degree of Master of Health Sciences Alexandra Fiona Hewydine Dinah Fakararo Smith to the degree of Master of Nursing with First Class Honours Rosemarie Adrian Coates Rene Susan Edwards Catherine Ann Fleckney Brian David Giberson and a Postgraduate Diploma in Health Sciences with Distinction in Advanced Nursing Louise Leonard and a Postgraduate Diploma in Health Sciences with Merit in Mental Health Nursing Helen Therese O'Shaughnessy to the degree of Master of Nursing with Second Class Honours First Division Josephine Elizabeth and Davis Wheaton to the degree of Master of Nursing with Second Class Honours Second Division Bridget Mary Killian and a Postgraduate Diploma in Health Sciences in Advanced Nursing Elaine Joyce McDonald Vicky Coral Thompson to the degree of Master of Public Health with First Class Honours Karen Marie Bartholomew and a Postgraduate Diploma in Public Health with Distinction Deborah Susan Hay Sarah Jane Hood and a Postgraduate Diploma in Public Health Catherine Mary Jackson Louise Bernadette McCarthy Amy Mae Rensford Kristi Jane Truwatha to the degree of Master of Public Health with Second Class Honours First Division Sean Burgess Bradley David Clark Jennifer Naumi Nahamaya Mungahera Nuran Raghaban Nikola Aivi Valiluaga Taabe to the degree of Master of Public Health with Second Class Honours Second Division Kartiga Kanisha Soana Moimoi Hiata and I call upon the Vice-Chancellor to present the Doctoral graduands Chancellor, I have the honour of presenting to you the Doctoral graduands to the degree of Doctor of Pharmacy John Allen Dunlop John investigated the practicalities of having clinical pharmacists work closely with heart failure patients to reduce the incidence of drug-related illness and improve their health status by optimising medication profiles. His research highlighted the need to develop collaborative relationships between general practitioners and clinical pharmacists by working together in the general practice environment. To the degree of Doctor of Philosophy Catherine Jane Ascoland in Obstetrics and Gynaecology University Doctoral Scholar Bright Future Top Achieva Doctoral Scholar Catherine investigated the mechanisms leading to the death of cell fragments of the placenta called syncytial knots that are shared into the maternal blood during pregnancy and how these fragments may help to protect the placenta and fetus from the maternal immune system. Her work may help us to understand the causes of diseases of pregnancy such as recurrent miscarriage and preeclampsia. Ursula Therese Evelie Byrne in Anatomy and Pharmacology Ursula has demonstrated that myeloperoxidase an enzyme which makes a toxic bleach substance may contribute to the loss of neurons seen in Alzheimer's disease. Inhibition of myeloperoxidase in the brain may represent a novel therapeutic strategy for Alzheimer's disease. Kenny Kwok Hinchong in Physiology Bright Future Top Achieva Doctoral Scholar Kenny investigated the role of specific cell membrane channels contributing to nerve cell damage in Parkinson's disease. Joanne Davidson in Physiology and Anatomy Bright Future Top Achieva Doctoral Scholar Joanne investigated the role of the connections between cells in spreading brain injury and in triggering abnormal activity in the developing brain. By blocking these connections for a short time after a period of low blood flow she was able to safely improve recovery of brain activity and reduce seizures confirming that these channels play a key role in extending brain injury. Helen Christine Isles in Community Health Helen explored the effects of tailored nutrition education on household supermarket food purchases in a diverse New Zealand population. Her findings suggest that approaches to improving population diets should include structural as well as individual behaviour change strategies. Peter Stewart Freestone in Physiology University Doctoral Scholar Peter investigated the cellular mechanisms of nerve cell damage by neurotoxins in models of Parkinson's disease. Steven Philip Jacobs in Medicine Steven developed a systematic process for health service funders and planners to use when developing and delivering new community health services for older people. Isuru Dilshane Jayasinga in Physiology Isuru investigated fundamental aspects of the distribution of proteins in heart muscle cells and revealed pictures with unprecedented detail. His work has opened the door to an improved understanding of structural changes that accompany heart failure. Elizabeth Jane Keata Holland in General Practice Elizabeth explored the everyday experiences of older adults living in a New Zealand rest home context to understand how residents made meaning in their day-to-day lives. The study finding revealed that the elders continue to participate in and actively manage satisfactory and fulfilling pastimes and relationships in their everyday life worlds. Andrew James Marshall in Maleketa Medicine Andrew investigated the mechanisms by which inhibitors of the enzyme PI3 kinase can specifically target different isoforms of this enzyme. Catherine Kahu McClintock in Psychiatry Kahu investigated some of the fundamental engagement processes based on whanau involvement and cultural respect needed to support Māori child and adolescent mental health service users. David Grant McNamara in Pediatrics David investigated whether using a heated humidifier to provide enhanced level of warmth and moisture improve the health of children with tracheostomies. Laura Elizabeth Myers in Community Health Laura developed an innovative approach for assessing the needs of disabled people and quantifying the resources required to live and thrive in our communities. Anubhav Mittal in Surgery University Doctoral Scholar Anubhav investigated three novel concepts in relation to acute pancreatitis. Cyclic Voltometry adapted from the wine industry for the real-time measurement of oxidative stress, the protein composition of mesenteric lymph to define the basis for its toxicity and mitochondrial dysfunction in end organs prone to failure in severe pancreatitis. Inhau Park in Pharmacology Bright Future Top Achieva Doctoral Scholar Inhau developed models of adult human brain neurogenesis to investigate some of the fundamental mechanisms of adult neurogenesis. It is hoped that these findings will aid in the development of therapies for neurodegenerative brain diseases. John Jeffrey Morgan Parsons in Health Sciences John investigated the impact of a designated goal facilitation tool on health-related quality of life, social support and physical function among a sample of community dwelling older people referred for home care. The study findings have significant national and international implications for designing and implementing models of care to assist older people to remain independent in their own homes. Praniti Patapati in Molecular Medicine Praniti investigated the possibility of a long-term treatment for adult stroke and its effects on stem cells in the brain. Finding from these studies holds significance in the field of a schemic stroke and present promising candidates for the treatment of this devastating medical emergency. Catherine Ann Perry in Nursing Kathy investigated the effects of an individualised physical activity programme in improving the quality of life and function in residents of aged care facilities. Steven Robert Ritchie in Molecular Medicine and Pathology Steven's research into human disease caused by Staphylococcus aureus has helped to explain why this bacterium affects Māori and Pacific people much more commonly than people of European or other ethnicities in Auckland. Darren Michael Sverskes in Pharmacy Darren explored the use of the conducting polymer polypyrol to achieve modifiable release of the anti-psychotic drugs drug risk paradigm. This technology could be utilised in implantable drug delivery systems where the dose could be adjusted by external signalling, optimising patient benefit to side effect ratios while simultaneously ensuring compliance. Carmel, Jane Williams in Community Health Carmel used a health and human rights framework to develop tools that can be used to guide the design of aid funded health programmes and to ensure that health aid is effective, appropriate and does no harm. Her work translates the right to health into practice, has direct application to aid programmes delivered in our Pacific region and draws on her work in Papua New Guinea. To the degree of Bachelor of Pharmacy with Second Class Honours First Division Ahmed Ismail Fafi Muhammad Mamush And in absentia all those other persons named in the Book of Convocation qualified for the conferment of a degree or the award of a diploma in the Faculty of Medical and Health Sciences. Teaching Excellence Awards The University places considerable significance on excellence in teaching. It recognises this by making awards each year to teachers who have demonstrated excellence in aspects of teaching. These awards are contestable across the University and signify a truly superior achievement. An award for excellence in postgraduate research supervision has been made to Professor Louise Nicholson in the Deanery within the Faculty of Medical and Health Sciences. I now call upon a student of that faculty Joanne Davidson to read the citation for Professor Nicholson. I'm delighted to speak about Professor Louise Nicholson's excellence as a research supervisor. I am one of many who have undertaken the journey to doctoral completion under her guidance. Over 21 years Louise has supervised students across the spectrum from honours projects to doctorates. She provides them all with a stimulating and challenging environment. At the start Louise carefully nurtures students guiding the development of a clear research direction. She then allows them the freedom to develop and expand their skills and interests while providing carefully targeted support. Louise exercises a duty of care that is exceptional. Always aware of any personal issues that might affect a student's ability to perform at his or her best. She provides wonderful support and directs students to other assistants as required. She works tirelessly to ensure that students gain access to international research leaders so they are able to pursue collaborative opportunities and to discuss future career options. As a result Louise's students are found across the world from Perth to Los Angeles Auckland to Oxford and beyond. Former students frequently seek out Louise's advice and guidance as they chart their own careers. She is always willing to facilitate introductions and provide assistance to help them progress. Louise has also exercised faculty-wide leadership to develop an environment that supports young researchers. Her supports of initiatives such as HealthEx and Chiasma assure students of the opportunities to present to a critical audience in a supportive environment. Louise exemplifies the successful researcher. She has enthusiasm, vigor and passion that she imparts to her students and is quite rightly held in the highest regard by them. They know what it is like to work with a staff member committed to ensuring that they achieve and succeed. It is a pleasure to present Louise Nicholson as a worthy recipient of a University of Auckland Teaching Excellence Award. I now call upon the Vice-Chancellor to present a fellow of the University of Auckland. I have a better signal next time. Just career limiting. Chancellor, I have pleasure in presenting to you Alison Patterson for the award of the honour fellow of the University of Auckland. Alison Patterson is being acknowledged today for her outstanding contribution to the University of Auckland through her role as the first chair of the board of the National Research Centre for Growth and Development, a centre of research excellence. Mrs Patterson joined the Board of Governance of the Centre at its inception in 2003 and has been the chair ever since. Her background is in corporate governance and leadership in the service and health industries. She has served as a director on numerous public sector and private organisation boards including the Board of the Reserve Bank, the Rights and Board, Chair of the Board of Land Corp Farming Limited, Chair of the Electricity Complaints Commission and Chair of Waitamata District Health Board. Alison is also a board member for another of the centres of research excellence hosted by the University of Auckland, Ngā Pae Ota Manamatanga and she is also a councillor of Massey University. This long history of excellence in governance has provided her with a breadth of experience and a wide range of skills. Indeed, in November 2003, Director Magazine profiled Alison Patterson calling her the Consimate Director. The National Research Centre for Growth and Development has a complex structure with multiple partners geographically spread across the country. The board under Alison's chairmanship has therefore had to steer a course through a complicated structure of responsibilities and interests. The wide respect in which Alison is held both by fellow members of the board and by members of the centre reflects not only her abilities as chair of the board but also her clear and genuine commitment to the centre and her desire to see it succeed and excel as a centre of research excellence. Alison Patterson has devoted a great deal of time, energy and skills to the governance of the centre and to the members taking her role as chair of the board very seriously and investing significant personal energy into ensuring the centre's success. She has taken a large administrative workload between meetings and has always made herself widely available to the executive team of the centre. This has extended to regular face-to-face meetings between board meetings, frequent contact and constant availability by telephone and email even when on holiday overseas. Alison has taken it upon herself to consult widely with members of the centre including travelling to the various geographical locations so that she can meet personally with investigators. Alison has been an active champion for the National Research Centre for Growth and Development both within the University of Auckland and in the wider community. She has been proactive in seeking engagement with chairs of the boards of other centres of research excellence and also with Government. The commitment that Alison has played as chair of the Board of Governance of the National Research Centre for Growth and Development has ensured that it has a solid foundation on which to continue to grow and which will ensure its ongoing success as a centre of research excellence. Chancellor, University Fellowships are awarded to those who make a unique and valuable contribution to the University. Alison Patterson's contribution has undoubtedly been both unique and valuable. I'm therefore delighted to present her to you for the award of a fellowship of the University of Auckland. On behalf of the University, can I now invite all today's graduates to stand and receive the congratulations of us all. It is unlikely you'll get a better opportunity for the graduates to show their appreciation of their families and supporters and the staff of the University who have helped them as they have achieved their qualifications. This concludes this meeting of council and convocation of the University for the conferment of degrees and the award of diplomas. I now invite you to sing the first verse of God Defend New Zealand in Māori and then in English. The words are printed on the reverse of the programmes.


Hello, everyone, and welcome to this week's Product School webinar. Thanks for joining us today. Just in case you didn't know, Product School teaches product management, coding, data analytics, digital marketing, UX design, and product leadership courses online and our 16 campuses worldwide. On top of that, every week we offer some amazing local product management events and host online webinars, live streams, and ask me anything sessions. Head over to productschool.com after this webinar to check them out. Hi, everyone. My name is Rihanna Zimmerman, and I am a senior product marketing manager. Today, I'm going to talk to you about buyer personas. I'm going to teach you how you can build your own set of buyer personas for your product and also how you can use them to drive customer centricity in your organization. Here's a few things you can expect to learn in this webinar. First, how to build out a set of buyer personas tailored to your product. Second, what kinds of questions you should ask to get the best information for your personas from your customer interviewees. And finally, how you can use personas to increase cross-team alignment and keep customer centricity the goal. Now, let's get into it. Hap Gemini recently released a study. They asked businesses if they thought that they were customer centric. 75% said yes. This is a pretty massive number. However, only 30% of consumers agreed that these businesses were customer centric. It's as important as ever to become customer centric. There's a lot of competition for these businesses and customers' expectations are ever increasing. So this is where buyer personas can help your business truly become more customer centric. One of the challenges buyer personas can help solve is a disconnection from customers' desires. As we saw in the Hap Gemini study, many businesses think that they're customer centric, but they're actually disconnected from their customers. Second, many businesses have a broken feedback loop. Some teams are able to correspond with customers, but that doesn't always mean that this information is fed back into the product strategy. Another challenge that buyer personas can help solve is silos between teams. We'll get more into that later. Let's talk about how these buyer personas can actually be used. First, they can ensure that your teams are keeping your customer at the center of your strategy with real feedback from customers. Second, they can help you facilitate a direct feedback loop with customers through opportunities like one-to-one interviews and surveys. Finally, they can help you create synergy among your teams. Buyer personas are a valuable resource, and once they're properly implemented into your organization, you'll be truly aligned with the rest of the company around what your customers want and needs are and how that should affect your product strategy. So you're interested in building buyer personas for your product. Where should you start? You should aim to create a list of two to five personas that you would like to build. The number of personas that you should build really will depend on the complexity of your product and sales cycle. There's a few different factors that go into these personas, including seniority, the team that the personas are on, the responsibilities of the persona, and the persona's role in decision-making. You may have a mix of personas that represent different areas of each of these factors. However, your most important persona will likely be your most senior persona, as this is the person that has the most buying power. Let's say that you are a product marketer for a marketing automation software, and you'd like to create a list of personas. Here's a sample approach. First, you have the chief marketing officer, as this is the person that owns the marketing technology budget. This is the person that your commercial teams need to influence the most and the one that your product teams also need to impress. And you have your director of digital marketing, who may be second in command to your CMO. Then you might have your marketing manager. This is likely the practitioner or the person that's actually going to be using the technology. And finally, you might have someone from another team, like IT. Even though IT might not be using the software, you might find that they are involved in the decision-making process, and so you may want to create a persona. Once you've nailed down your list of personas and validated with someone from your commercial team to make sure that you're thinking of the right people, you'll want to formulate a list of questions that you'll use in the interview and research gathering process. The questions should be based upon the specific demographic information, such as name, age, job related, such as what kinds of responsibilities does this person have, success related, such as how do you measure your success, decision-making questions, such as what kind of sources do you use to learn about new technology, and product related, such as which vendors do you use to currently do your marketing automation. Remember that you should be seen as objective as possible, though you are in a way representing your company. You should be a seemingly neutral party, so you can gather research. So when you're formulating your questions, you shouldn't have influences from your specific product, or you shouldn't refer to other vendors as competitors. Here's a list of sample questions that you might want to ask. We have the demographic information on top, and we have information about the person's title and company. Then there's questions about the person's specific role, such as how long they have been in it, which team they report into, and their responsibilities. Then we'll find out about their key challenges, how they measure their success, and then some decision-making questions, such as how do you learn more about the industry, and do you make the decisions around purchasing new technology. Finally, we have the product-related questions. Once you're happy with your set of questions, it's a good idea to share these with contacts in advance so that they can be fully prepared. So now let's talk about who you should interview at this stage. Existing customers or prospective clients can make great interview subjects, as they are likely the target that you are trying to reach. However, remember that you might want to be sensitive about these relationships. If you have relationships with these clients or someone that you know within your organization does, these are key. These are great gateways for you to have open conversation. You also want to find somebody that has 30 minutes to spare to speak with you. Let's talk about how to conduct these interviews effectively. When you're reaching out to this person or early on in the conversation, you should make it clear that you're not trying to sell them anything. You're talking to them as marketer to marketer or peer to peer. Ask questions if you do not understand or if you'd like more information. It may take the contact a couple of questions to warm up. So don't be afraid to ask them for more detail so you can get as much information as possible. Pay very close attention to the specific language that they use to describe their role and make note of it. If you hear a certain phrase repeatedly in the interviews, this is definitely something that you should write down as you should be creating a product and positioning that shows that you speak the language of your customers. You can conduct the interview either face to face or by video call. A phone call is okay too. But the personal aspect of having face to face communication may make the contact more comfortable. You should interview three to five people per persona. You shouldn't base your persona on just one person as they may share information that is only specific to them. It's important to validate and use the proper sample size to make sure it accurately represents that person's role. After you've interviewed three to five people and you have all of your data, now you'll build out the final persona. You should compile the information into a document. It may be one to two pages and you should be sure to capture all of the same information and criteria in each of the different personas. So if you decide that you want to show the name, age, key responsibilities and measures of success in your persona, they should be consistent across the board. You should highlight information that has either come up often in your interviews or something that you think can greatly influence the way your organization understands your buyers. Now that you have your final personas, here's how you can actually start using them. You can build product messaging that caters to these personas' unique roles, challenges and traits. So you may have positioning that's tailored to your CMO persona and other messaging that's tailored to your marketing manager. This should be one of your first steps if you're launching a product, as this is a great way to ensure that you're truly keeping your customers' needs at the center. You should also share these personas with relevant departments. Use your discretion to determine who will care most about this information and also ask them for feedback. Think of your personas as living, breathing documents. They will evolve over time, so you should be open to hearing from those who are experts on your customer to validate if your personas accurately represent your customers. Finally, here is where you can truly drive customer centricity. Map out the decision-making journey for each persona based on the information you've gathered. Then you can activate different teams to create personalized experiences for each persona. Whether it's on your website, through content, or through the product itself, you can ensure, using these personas, that these things speak to that specific persona. So after you've truly activated these personas in your organization, what can you expect? First, your product and positioning should truly resonate with your customer. This means a few things. First, your sales teams will be able to close more deals. And second, your customer will be happy using your product and they'll keep coming back for more. Next, you'll no longer need to do guesswork to understand your customer's needs. You'll know that your personas have influenced your product and your positioning. And you'll know that their voice is truly captured in these personas that you've built. Finally, your teams will leverage your personas as a source of truth. Once you've been able to roll out the personas and leverage them in your organization, your organization will have trust in the fact that you understand your buyers and you know who you're selling to. Thank you so much for tuning in to our webinar on buyer personas. If you have any questions about personas, please feel free to reach out to me. Thank you and hope to see you again.


Okay, so let's try this one, Rene. So, um, osmium tetroxide, whenever you see this, and you see an alkene, whenever you see an osmium tetroxide, that thing's gonna, yeah, make a diol out of the alkene, okay? And in fact, whenever you have an alkene, just like the last problem we were talking about, you've got these carbons being sp2 centers, right? So the thing can attack from the top or the bottom, you know? This particular one's going to want to attack from the bottom more because of this... Breachhead. Yeah, this Breachhead carbon, and that provides steric hindrance to something coming that way, so it's not going to do it, right? So, um, I mean, so you're thinking that the major product of this is going to be the diol from the bottom, right? So, um, how do you do that? Remember, this is actually a conservative reaction, okay? It's like those, um, uh, pericyclic reactions that we had talked about later, you know? But now that you know about them, you can think about them in this sort of way. So let's draw Osmium tetroxide. Well, that's what it looks like, okay? It's unlike potassium permanganated, uh, uncharged, okay? So, um, what'll happen is, again, this is a concerted reaction, so pericyclic, it'll...all the bonds form and break at the exact same time. So, what I like to do is take that... Yeah, let's just draw a little bit better. And then this bond, this is weird because you don't usually see things attacking oxygens, but with the last two mechanisms that we've done, things have been attacking oxygens, right? And then that bond goes there, okay? Now you've got this intermediate. Again, this is concerted. And you don't need to know the second step mechanism. So this is kind of an intermediate, right? Or, uh, uh, intermediate for the reaction. And what this sodium bisulfite does is kind of reduce this Osmonium intermediate, you know? So it'll kind of, if you can effectively say, just break those bonds there, okay? So it's going to reduce it, right? So reducing means to add hydrogen to it, right? So for this, um, you don't need to know any mechanism. If you see something like that, that just means reduction. What is that called? Standard hydroxylation. Yeah, well, it's a syn-dial. Yeah. And the reaction is, like René just said, syn-dial hydroxylation. So, again, need to know the mechanism? If you need to know the mechanism, just reduce it, okay? So this, in fact, is oxidizing that thing, right? Because if you add oxygen to it. Yeah, oxidizing. Okay. Is everybody cool with that? Yeah. Okay, cool.